Immunitrack is a novel spin-out company from the University of Copenhagen that builds on more than a decade of research in the neonatal Fc receptor (FcRn) and Major Histocompablility Complex Molecules (MHC).

The biotinylated MHC molecules from Immunitrack have proven their performance as assay reagents in several large scale NIH funded projects, as a way of example approximately 100.000 affinity measurements in the Immune Epitope Database (EIDB) are based on these protocols. Additionally our biotinylated MHC II molecules have served as superior tetramer reagents in several peer reviewed articles. The combination of our assay technology and supporting MHC I/II molecules for staining or expansion of CD4/8 T cells makes us the ideal partner in any immunogenicity, vaccine or immunotherapy project.

Immunitrack supply FcRn molecules from a variety of species, the molecules can be enzymatically biotinylated at the C terminus of the FcRn heavy chain enabling IgG and albumin to bind at the same time. The molecules are captured on IgG sepharose and therefore 100 percent active, the molecules have been tested and show superior performance on a variety of assay platforms: ELISA, AlphaScreen, BLI (Octet) and SPR (Biacore).